"Hyperoxaluria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Excretion of an excessive amount of OXALATES in the urine.
| Descriptor ID |
D006959
|
| MeSH Number(s) |
C12.777.419.313 C13.351.968.419.313
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperoxaluria".
Below are MeSH descriptors whose meaning is more specific than "Hyperoxaluria".
This graph shows the total number of publications written about "Hyperoxaluria" by people in this website by year, and whether "Hyperoxaluria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperoxaluria" by people in Profiles.
-
End Point Considerations for Clinical Trials in Enteric Hyperoxaluria. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1637-1644.
-
Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells. Am J Physiol Cell Physiol. 2023 07 01; 325(1):C344-C361.
-
What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
-
Pathophysiology and Treatment of Enteric Hyperoxaluria. Clin J Am Soc Nephrol. 2021 03 08; 16(3):487-495.
-
Activation of the PKA signaling pathway stimulates oxalate transport by human intestinal Caco2-BBE cells. Am J Physiol Cell Physiol. 2020 02 01; 318(2):C372-C379.
-
Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria. Am J Physiol Gastrointest Liver Physiol. 2019 01 01; 316(1):G1-G14.
-
Adenosinergic signaling inhibits oxalate transport by human intestinal Caco2-BBE cells through the A2B adenosine receptor. Am J Physiol Cell Physiol. 2018 11 01; 315(5):C687-C698.
-
Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria. Kidney Int. 2018 05; 93(5):1098-1107.
-
Urine kidney injury markers do not increase following gastric bypass: a multi-center cross-sectional study. Can J Urol. 2018 02; 25(1):9199-9204.
-
Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass. Gastroenterology. 2017 04; 152(5):1055-1067.e3.